SCYL1 and uveal melanoma: LIHC (liver hepatocellular carcinoma), LUSC (lung squamous cell carcinoma), NKTL (T-cell lymphoma) and UVM (uveal melanoma), were only evaluated in pan-cancer analyses due to insufficient sample-size for per-cancer analyses.